Role of genomic instability in arsenic-induced carcinogenicity. A review

Environment International

Volumn 53, Issue , 2013, Pages 29-40

  Bhattacharjee, Pritha ^a,b   Banerjee, Mayukh ^a   Giri, Ashok K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Arsenic; Chromosomal instability; DNA level instability; Genomic instability; Microsatellite instability; Review

Indexed keywords

ALKYLATION; ARSENIC; CELL DEATH; CHEMICAL CONTAMINATION; CHROMOSOMES; DISEASES; DNA; DNA SEQUENCES; GENE EXPRESSION; PATHOLOGY; REVIEWS; RNA;

ARSENIC TOXICITY; CANCER CELLS; CANCER RISK; CELLULAR PATHWAY; CHROMOSOMAL INSTABILITY; DAMAGED CELLS; DNA DAMAGES; DNA REPAIR; EPIGENETIC REGULATION; EXOGENOUS FACTORS; GENE EXPRESSION PROFILING; GENETIC ALTERATIONS; GENOME-WIDE ASSOCIATION; GENOMIC INSTABILITY; MICROSATELLITE INSTABILITY; MITOTIC ARREST; PRO-APOPTOTIC GENES; PROMOTER METHYLATION; STATE OF RESEARCH; TELOMERES;

STABILITY;

ARSENIC; ARSENIC TRIOXIDE; DNA; HEAT SHOCK PROTEIN 90; MICRORNA; PACLITAXEL;

ARSENIC; CANCER; CARCINOGEN; CHROMOSOME; DNA; GENE EXPRESSION; GENOME; GENOMICS; POLLUTION EXPOSURE; TOXICITY;

APOPTOSIS; ARSENIC INDUCED CARCINOGENICITY; CANCER RISK; CARCINOGENICITY; CELL CYCLE CHECKPOINT; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; DIET; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION PROFILING; GENE MUTATION; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOMIC INSTABILITY; HUMAN; MICROSATELLITE INSTABILITY; MITOSIS; MITOSIS INHIBITION; MOLECULAR INTERACTION; MULTIFACTORIAL INHERITANCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SHORT TANDEM REPEAT; TELOMERE;

EID: 84872202934     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2012.12.004     Document Type: Review

References (232)

1. Aguilera A., Gómez-González B. Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet 2008, 9:204-217.
2. Agusa T., Fujihara J., Takeshita H., Iwata H. Individual variations in inorganic arsenic metabolism associated with AS3MT genetic polymorphisms. Int J Mol Sci 2011, 12:2351-2382.
3. Akiyama M., Yamada O., Kanda N., Akita S., Kawano T., Ohno T., et al. Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Lett 2002, 178:187-197.
4. Allen R.G., Tresini M. Oxidative stress and gene regulation. Free Radic Biol Med 2000, 28:463-499.
5. Ammendola R., Mesuraca M., Russo T., Cimino F. The DNA-binding efficiency of Sp1 is affected by redox changes. Eur J Biochem 1994, 225:483-489.
6. Anders M., Mattow J., Digweed M., Demuth I. Evidence for hSNM1B/Apollo functioning in the HSP70 mediated DNA damage response. Cell Cycle 2009, 8:1725-1732.
7. Andrew A.S., Karagas M.R., Hamilton J.W. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int J Cancer 2003, 104:263-268.
8. Andrew A.S., Burgess J.L., Meza M.M., Demidenko E., Waugh M.G., Hamilton J.W., et al. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Perspect 2006, 114:1193-1198.
9. Applebaum K.M., Karagas M.R., Hunter D.J., Catalano P.J., Byler S.H., Morris S., et al. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Environ Health Perspect 2007, 115:1231-1236.
10. Arita A., Shamy M.Y., Chervona Y., Clancy H.A., Sun H., Hall M.N., et al. The effect of exposure to carcinogenic metals on histone tail modifications and gene expression in human subjects. J Trace Elem Med Biol 2012, 26:174-178.
11. Banerjee M., Sarkar J., Das J.K., Mukherjee A., Sarkar A.K., Mondal L., et al. Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations. Carcinogenesis 2007, 28:672-676.
12. Banerjee M., Sarma N., Biswas R., Roy J., Mukherjee A., Giri A.K. DNA repair deficiency leads to susceptibility to develop arsenic-induced premalignant skin lesions. Int J Cancer 2008, 123:283-287.
13. Banerjee N., Banerjee M., Ganguly S., Bandyopadhyay S., Das J.K., Bandyopadhay A., et al. Arsenic-induced mitochondrial instability leading to programmed cell death in the exposed individuals. Toxicology 2008, 246:101-111.
14. Banerjee M., Banerjee N., Ghosh P., Das J.K., Basu S., Sarkar A.K., et al. Evaluation of the serum catalase and myeloperoxidase activities in chronic arsenic-exposed individuals and concomitant cytogenetic damage. Toxicol Appl Pharmacol 2010, 249:47-54.
15. Banerjee M., Bhattacharjee P., Giri A.K. Arsenic-induced cancers: a review with special reference to gene, environment and their interaction. Genes Environ 2011, 33:128-140.
16. Barnes J.A., Collins B.W., Dix D.J., Allen J.W. Effects of heat shock protein 70 (Hsp70) on arsenite-induced genotoxicity. Environ Mol Mutagen 2002, 40:236-242.
17. Basu A., Ghosh P., Das J.K., Banerjee A., Ray K., Giri A.K. Micronuclei as biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in three cell types. Cancer Epidemiol Biomarkers Prev 2004, 13:820-827.
18. Basu A., Som A., Ghoshal S., Mondal L., Chaubey R.C., Bhilwade H.N., et al. Assessment of DNA damage in peripheral blood lymphocytes of individuals susceptible to arsenic induced toxicity in West Bengal India. Toxicol Lett 2005, 159:100-112.
19. Bau D.T., Wang T.S., Chung C.H., Wang A.S., Wang A.S., Jan K.Y. Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite. Environ Health Perspect 2002, 110:753-756.
20. Bergoglio V., Pillaire M.J., Lacroix-Triki M., Raynaud-Messina B., Canitrot Y., Bieth A., et al. Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. Cancer Res 2002, 62:3511-3514.
21. Bloomfield C.D., Trent J.M., Ban Den Berghe D. Report of the committee on structural chromosomal changes in neoplasi, human gene mapping 9: ninth international workshop on human gene mapping. Cytogenet Cell Genet 1987, 46:344-346.
22. Boffetta P., van der Hel O., Norppa H., Fabianova E., Fucic A., Gundy S., et al. Chromosomal aberrations and cancer risk: results of a cohort study from central Europe. Am J Epidemiol 2007, 165:36-43.
23. Bojovic B, Crowe DL. Dysfunctional telomeres promote genomic instability and metastasis in the absence of telomerase activity in oncogene induced mammary cancer. Mol Carcinog in press.
24. Breivik J., Gaudernack G. Genomic instability, DNA methylation and natural selection in colorectal carcinogenesis. Semin Cancer Biol 1999, 9:245-254.
25. Breton C.V., Zhou W., Kile M.L., Houseman E.A., Quamruzzaman Q., Rahman M., et al. Susceptibility to arsenic-induced skin lesions from polymorphisms in base excision repair genes. Carcinogenesis 2007, 28:1520-1525.
26. Cai X., Yu Y., Huang Y., Zhang L., Jia P.M., Zhao Q., et al. Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells. Leukemia 2003, 17:1333-1337.
27. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
28. Canitrot Y., Frechet M., Servant L., Cazaux C., Hoffmann J.S. Overexpression of DNA polymerase beta: a genomic instability enhancer process. FASEB J 1999, 13:1107-1111.
29. Carré M., Carles G., André N., Douillard S., Ciccolini J., Briand C., et al. Involvement of microtubules and mitochondria in the antagonism of arsenic trioxide on paclitaxel-induced apoptosis. Biochem Pharmacol 2002, 63:1831-1842.
30. Chen G.Q., Zhu J., Shi X.G., Ni J.H., Zhong H.J., Si G.Y., et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-Raα/PML proteins. Blood 1996, 88:1052-1061.
31. Chen H.J., Cho C.L., Liang C.L., Chen L., Chang H.W., Lu K., et al. Differential telomerase expression and telomere length in primary intracranial tumors. Chang Gung Med J 2001, 24:352-360.
32. Chen Y.C., Guo Y.L., Su H.J., Hsueh Y.M., Smith T.J., Ryan L.M., et al. Arsenic methylation and skin cancerrisk in southwestern Taiwan. J Occup Environ Med 2003, 45:241-248.
33. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
34. Chen Y.J., Lin Y.P., Chow L.P., Lee T.C. Proteomic identification of Hsp70 as a new Plk1 substrate in arsenic trioxide-induced mitotically arrested cells. Proteomics 2011, 11:4331-4345.
35. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., et al. p53 deficiency rescues thae adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97:527-538.
36. Chin K., de Solorzano C.O., Knowles D., Jones A., Chou W., Rodriguez E.G., et al. In situ analyses of genome instability in breast cancer. Nat Genet 2004, 36:984-988.
37. Chiou H.Y., Chiou S.T., Hsu Y.H., Chou Y.L., Tseng C.H., Wei M.L., et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 2001, 153:411-418.
38. Chou W.C., Hawkins A.L., Barrett J.F., Griffin C.A., Dang C.V. Arsenic inhibition of telomerase transcription leads to genetic instability. J Clin Invest 2001, 108:1541-1547.
39. Chow J.P., Siu W.Y., Fung T.K., Chan W.M., Lau A., Arooz T., et al. DNA damage during the spindle-assembly checkpoint degrades CDC25A, inhibits cyclin-CDC2 complexes, and reverses cells to interphase. Mol Biol Cell 2003, 14:3989-4002.
40. Chung C.J., Huang C.J., Pu Y.S., Su C.T., Huang Y.K., Chen Y.T., et al. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma. Toxicol Appl Pharmacol 2008, 232:203-209.
41. Colognato R., Coppedè F., Ponti J., Sabbioni E., Migliore L. Genotoxicity induced by arsenic compounds in peripheral human lymphocytes analysed by cytokinesis-block micronucleus assay. Mutagenesis 2007, 22:255-261.
42. Coppé J.P., Patil C.K., Rodier F., Sun Y., Muñoz D.P., Goldstein J., et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008, 6:2853-2868.
43. Cui Y., Han Z., Hu Y., Song G., Hao C., Xia H., et al. MicroRNA-181b and microRNA-9 mediate arsenic-induced angiogenesis via NRP1. J Cell Physiol 2012, 227:772-783.
44. Davis A.P., Murphy C.G., Rosenstein M.C., Wiegers T.C., Mattingly C.J. The comparative toxicogenomics database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study. BMC Med Genomics 2008, 9:1-48.
45. De Chaudhuri S., Mahata J., Das J.K., Mukherjee A., Ghosh P., Sau T.J., et al. Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 2006, 601:102-112.
46. De Chaudhuri S., Kundu M., Banerjee M., Das J.K., Majumdar P., Basu S., et al. Arsenic-induced health effects and genetic damage in keratotic individuals:involvement of p53 arginine variant and chromosomal aberrations in arsenic susceptibility. Mutat Res 2008, 659:118-125.
47. De Vizcaya-Ruiz A., Barbier O., Ruiz-Ramos R., Cebrian M.E. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res 2009, 674:85-92.
48. Ding W., Hudson L.G., Liu K.J. Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol Cell Biochem 2005, 279:105-112.
49. Ding W., Liu W., Cooper K.L., Qin X.J., de Souza Bergo P.L., Hudson L.G., et al. Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage. J Biol Chem 2009, 284:6809-6817.
50. Dong Z. The molecular mechanisms of arsenic-induced cell transformation and apoptosis. Environ Health Perspect 2002, 110:757-759.
51. Draviam V.M., Xie S., Sorger P.K. Chromosome segregation and genomic stability. Curr Opin Genet Dev 2004, 14:120-125.
52. Drobná Z., Waters S.B., Walton F.S., LeCluyse E.L., Thomas D.J., Stýblo M. Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. Toxicol Appl Pharmacol 2004, 201:166-177.
53. Duan X.F., Wu Y.L., Xu H.Z., Zhao M., Zhuang H.Y., Wang X.D., et al. Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes. Chem Biol Interact 2010, 183:222-230.
54. Dulak A.M., Schumacher S.E., van Lieshout J., Imamura Y., Fox C., Shim B., et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res 2012, 72:4383-4393.
55. Dulout F.N., Grillo C.A., Seoane A.I., Maderna C.R., Nilsson R., Vahter M., et al. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat Res 1996, 370:151-158.
56. Ebert F., Weiss A., Bültemeyer M., Hamann I., Hartwig A., Schwerdtle T. Arsenicals affect base excision repair by several mechanisms. Mutat Res 2011, 715:32-41.
57. Eguchi N., Kuroda K., Endo G. Metabolites of arsenic induced tetraploids and mitotic arrest in cultured cells. Arch Environ Contam Toxicol 1997, 32:141-145.
58. Eguchi R., Fujimori Y., Takeda H., Tabata C., Ohta T., Kuribayashi K., et al. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells. J Cell Physiol 2011, 226:762-768.
59. El-Ghor A.A., Noshy M.M., Eid J.I. Lead acetate and arsenic trioxide induce instability of microsatellites at three different fragile sites (6q21, 9q32-9q33 and 15p14) within the genome of the rat. Mutat Res 2011, 726:195-199.
60. El-Murr N., Abidi Z., Wanherdrick K., Svrcek M., Gaub M.P., Fléjou J.F., et al. MiRNA genes constitute new targets for microsatellite instability in colorectal cancer. PLoS One 2012, 7:e31862.
61. Ferrario D., Collotta A., Carfi M., Bowe G., Vahter M., Hartung T., et al. Arsenic induces telomerase expression and maintains telomere length in human cord blood cells. Toxicology 2009, 260:132-141.
62. Flora S.J. Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 2011, 51:257-281.
63. Fu Y., Yi Z., Wu X., Li J., Xu F. Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol 2011, 49:4246-4251.
64. Fung H., Liu P., Demple B. ATF4-dependent oxidative induction of the DNA repair enzyme Ape1 counteracts arsenite cytotoxicity and suppresses arsenite-mediated mutagenesis. Mol Cell Biol 2007, 27:8834-8847.
65. Gamble M.V., Liu X., Slavkovich V., Pilsner J.R., Ilievski V., Factor-Litvak P., et al. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr 2007, 86:1202-1209.
66. Gao W., Liu L., Lu X., Shu Y. Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma. Clin Lung Cancer 2011, 12:14-17.
67. Ghosh P., Basu A., Mahata J., Basu S., Sengupta M., Das J.K., et al. Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water. Int J Cancer 2006, 118:2470-2478.
68. Ghosh P., Banerjee M., De Chaudhuri S., Das J.K., Sarma N., Basu A., et al. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic. Mutat Res 2007, 15:104-110.
69. Ghosh P., Basu A., Singh K.K., Giri A.K. Evaluation of cell types for assessment of cytogenetic damage in arsenic exposed population. Mol Cancer 2008, 7:45.
70. Gomez-Rubio P., Roberge J., Arendell L., Harris R.B., O'Rourke M.K., Chen Z., et al. Association between body mass index and arsenic methylation efficiency in adult women from southwest U.S. and northwest Mexico. Toxicol Appl Pharmacol 2011, 252:176-182.
71. Gonsebatt M.E., Vega L., Salazar A.M., Montero R., Guzmán P., Blas J., et al. Cytogenetic effects in human exposure to arsenic. Mutat Res 1997, 386:219-228.
72. González-Suárez E., Samper E., Flores J.M., Blasco M.A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 2000, 26:114-117.
73. Griffith J.K., Bryant J.E., Fordyce C.A., Gilliland F.D., Joste N.E., Moyzis R.K. Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma. Breast Cancer Res Treat 1999, 54:59-64.
74. Guillamet E., Creus A., Ponti J., Sabbioni E., Fortaner S., Marcos R. In vitro DNA damage by arsenic compounds in a human lymphoblastoid cell line (TK6) assessed by the alkaline Comet assay. Mutagenesis 2004, 19:129-135.
75. Gurr J.R., Lin Y.C., Ho I.C., Jan K., Lee T.C. Induction of chromatid breaks and tetraploidy in Chinese hamster ovary cells by treatment with sodium arsenite during the G2 phase. Mutat Res 1993, 319:135-142.
76. Halicka H.D., Smolewski P., Darzynkiewicz Z., Dai W., Traganos F. Arsenic trioxide arrests cells early in mitosis leading to apoptosis. Cell Cycle 2002, 1:201-209.
77. Hamadeh H.K., Trouba K.J., Amin R.P., Afshari C.A., Germolec D. Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes. Toxicol Sci 2002, 69:306-316.
78. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
79. Hartwig A. Carcinogenicity of metal compounds: possible role of DNA repair inhibition. Toxicol Lett 1998, 102-103:235-239.
80. Hartwig A., Groblinghoff U.D., Beyersmann D., Natarajan A.T., Filon R., Mullenders L.H. Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis 1997, 18:399-405.
81. Hartwig A., Blessing H., Schwerdtle T., Walter I. Modulation of DNA repair processes by arsenic and selenium compounds. Toxicology 2003, 193:161-169.
82. Hasley P.B., Follansbee W.P., Coulehan J.L. Cardiac manifestations of Churg-Strauss syndrome: report of a case and review of the literature. Am Heart J 1990, 120:996-999.
83. Heck J.E., Nieves J.W., Chen Y., Parvez F., Brandt-Rauf P.W., Graziano J.H., et al. Dietary intake of methionine, cysteine, and protein and urinary arsenic excretion in Bangladesh. Environ Health Perspect 2009, 117:99-104.
84. Hernández-Zavala A., Córdova E., Del Razo L.M., Cebrián M.E., Garrido E. Effects of arsenite on cell cycle progression in a human bladder cancer cell line. Toxicology 2005, 207:49-57.
85. Hiyama E., Hiyama K., Yokoyama T., Shay J.W. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 2001, 3:17-26.
86. Holt S.E., Glinsky V.V., Ivanova A.B., Glinsky G.V. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability. Mol Carcinog 1999, 25:241-248.
87. Hu Y., Su L., Snow E.T. Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes. Mutat Res 1998, 408:203-218.
88. Huang S.C., Lee T.C. Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells. Carcinogenesis 1998, 19:889-896.
89. Huang T.S., Shu C.H., Chao Y., Chen S.N., Chen L.L. Activation of MAD 2 checkprotein and persistence of cyclin B1/CDC 2 activity associate with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis 2000, 5:235-241.
90. Hudler P. Genetic aspects of gastric cancer instability. Scientific World Journal 2012, 2012:761909.
91. Hunt C.R., Dix D.J., Sharma G.G., Pandita R.K., Gupta A., Funk M., et al. Genomic instability and enhanced radiosensitivity in Hsp70.1- and Hsp70.3-deficient mice. Mol Cell Biol 2004, 24:899-911.
92. Intarasunanont P., Navasumrit P., Woraprasit S., Chaisatra K., Suk W.A., Mahidol C., et al. Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ Health 2012, 11:31.
93. Jiang X.H., Wong B.C., Yuen S.T., Jiang S.H., Cho C.H., Lai K.C., et al. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Int J Cancer 2001, 91:173-179.
94. Jiao Y., Zhang W., Liu J., Ni W., Xu W., Jin J., et al. Telomere attrition and chromosome instability via downregulation of TRF2 contributes to arsenic trioxide-induced apoptosis of human T-Cell leukemia cell line molt-4 cells. Cancer Biol Ther 2007, 6:1186-1192.
95. Kessel M., Liu S.X., Xu A., Santella R., Hei T.K. Arsenic induces oxidative DNA damage in mammalian cells. Mol Cell Biochem 2002, 234-235:301-308.
96. Kile M.L., Baccarelli A., Tarantini L., Hoffman E., Wright R.O., Christiani D.C. Correlation of global and gene-specific DNA methylation in maternal-infant pairs. PLoS One 2010, 5:e13730.
97. Kipling D., Cooke H.J. Hypervariable ultra-long telomeres in mice. Nature 1990, 47:400-402.
98. Kligerman A.D., Tennant A.H. Insights into the carcinogenic mode of action of arsenic. Toxicol Appl Pharmacol 2007, 222:281-288.
99. Kligerman A.D., Doerr C.L., Tennant A.H., Harrington-Brock K., Allen J.W., Winkfield E., et al. Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Environ Mol Mutagen 2003, 42(3):192-205.
100. Kligerman A.D., Doerr C.L., Tennant A.H. Oxidation and methylation status determine the effects of arsenic on the mitotic apparatus. Mol Cell Biochem 2005, 279:113-121.
101. Kolodner R.D., Marsischky G.T. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999, 9:89-96.
102. Komissarova E.V., Rossman T.G. Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. Toxicol Appl Pharmacol 2010, 243:399-404.
103. Kunkel T.A. The mutational specificity of DNA polymerase-beta during in vitro DNA synthesis. Production of frameshift, base substitution, and deletion mutations. J Biol Chem 1985, 260:5787-5796.
104. Lai Y., Zhao W., Chen C., Wu M., Zhang Z. Role of DNA polymerase beta in the genotoxicity of arsenic. Environ Mol Mutagen 2011, 52:460-468.
105. Lambrou A., Baccarelli A., Wright R.O., Weisskopf M., Bollati V., Amarasiriwardena C., et al. Arsenic exposure and DNA methylation among elderly men. Epidemiology 2012, 23:668-676.
106. Lee T.C., Ho I.C. Differential cytotoxic effects of arsenic on human and animal cells. Environ Health Perspect 1994, 102:101-105.
107. Lee T.C., Ko J.L., Jan K.Y. Differential cytotoxicity of sodium arsenite in human fibroblasts and Chinese hamster ovary cells. Toxicology 1989, 56:289-299.
108. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature 1998, 396:643-649.
109. Lerda D. Sister-chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water. Mutat Res 1994, 312:111-120.
110. Lewińska D., Palus J., Stepnik M., Dziubałtowska E., Beck J., Rydzyński K., et al. Micronucleus frequency in peripheral blood lymphocytes and buccal mucosa cells of copper smelter workers, with special regard to arsenic exposure. Int Arch Occup Environ Health 2007, 80:371-380.
111. Li Y.M., Broome J.D. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells. Cancer Res 1999, 59:776-780.
112. Li W., Chou I.N. Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol Appl Pharmacol 1992, 114:132-139.
113. Li J., Rossman T. Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea. Biol Trace Elem 1989, 21:373-381.
114. Li D., Morimoto K., Takeshita T., Lu Y. Formamidopyrimidine-DNA glycosylase enhances arsenic-induced DNA strand breaks in PHA-stimulated and unstimulated human lymphocytes. Environ Health Perspect 2001, 109:523-526.
115. Li X., Pi J., Li B., Xu Y., Jin Y., Sun G. Urinary arsenic speciation and its correlation with 8-OHdG in Chinese residents exposed to arsenic through coal burning. Bull Environ Contam Toxicol 2008, 81:406-411.
116. Li Y., Ling M., Xu Y., Wang S., Li Z., Zhou J., et al. The repressive effect of NF-kappaB on p53 by mot-2 is involved in human keratinocyte transformation induced by low levels of arsenite. Toxicol Sci 2010, 116:174-182.
117. Li X., Shi Y., Wei Y., Ma X., Li Y., Li R. Altered expression profiles of microRNAs upon arsenic exposure of human umbilical vein endothelial cells. Environ Toxicol Pharmacol 2012, 34:381-387.
118. Liao C.T., Tung-Chieh Chang J., Wang H.M., Chen I.H., Lin C.Y., Chen T.M., et al. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma. Head Neck 2004, 6:504-512.
119. Liao W.T., Lin P., Cheng T.S., Yu H.S., Chang L.W. Arsenic promotes centrosome abnormalities and cell colony formation in p53 compromised human lung cells. Toxicol Appl Pharmacol 2007, 225:162-170.
120. Ling Y.H., Jiang J.D., Holland J.F., Perez-Soler R. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol 2002, 62:529-538.
121. Ling M., Li Y., Xu Y., Pang Y., Shen L., Jiang R., et al. Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation. Free Radic Biol Med 2012, 52:1508-1518.
122. Liou S.H., Lung J.C., Chen Y.H., Yang T., Hsieh L.L., Chen C.J., et al. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res 1999, 59:1481-1484.
123. Liu L., Trimarchi J.R., Navarro P., Blasco M.A., Keefe D.L. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability and apoptosis. J Biol Chem 2003, 278:31998-32004.
124. Loenen W.A. S-adenosylmethionine: jack of all trades and master of everything?. Biochem Soc Trans 2006, 34:330-333.
125. Lombard D.B., Chua K.F., Mostoslavsky R., Franco S., Gostissa M., Alt F.W. DNA repair, genome stability, and aging. Cell 2005, 120:497-512.
126. Lu C, Zhao F, Sun D, Zhong Y, Yu X, Li G, et al. Comparison of speciated arsenic levels in the liver and brain of mice between arsenate and arsenite exposure at the early life. Environ Toxicol in press.
127. Lynn S., Lai H.T., Gurr J.R., Jan K.Y. Arsenite retards DNA break rejoining by inhibiting DNA ligation. Mutagenesis 1997, 12:353-358.
128. Lynn S., Gurr J.R., Lai H.T., Jan K.Y. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res 2000, 86:514-519.
129. Mahata J., Basu A., Ghoshal S., Sarkar J.N., Roy A.K., Poddar G., et al. Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 2003, 534:133-143.
130. Mäki-Paakkanen J., Kurttio P., Paldy A., Pekkanen J. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ Mol Mutagen 1998, 32:301-313.
131. Marsit C.J., Eddy K., Kelsey K.T. MicroRNA responses to cellular stress. Cancer Res 2006, 66:10843-10848.
132. Martínez V., Creus A., Venegas W., Arroyo A., Beck J.P., Gebel T.W., et al. Evaluation of micronucleus induction in a Chilean population environmentally exposed to arsenic. Mutat Res 2004, 564:65-74.
133. Martínez V., Creus A., Venegas W., Arroyo A., Beck J.P., Gebel T.W., et al. Micronuclei assessment in buccal cells of people environmentally exposed to arsenic in northern Chile. Toxicol Lett 2005, 155:319-327.
134. Matsui M., Nishigori C., Toyokuni S., Takada J., Akaboshi M., Ishikawa M., et al. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease. J Invest Dermatol 1999, 113:26-31.
135. McCollum G., Keng P.C., States J.C., McCabe M.J. Arsenite delays progression through each cell cycle phase and induces apoptosis following G2/M arrest in U937 myeloid leukemia cells. J Pharmacol Exp Ther 2005, 313:877-887.
136. McCormick A., Campisi J. Cellular aging and senescence. Curr Opin Cell Biol 1991, 3:230-234.
137. McNeely S.C., Taylor B.F., States J.C. Mitotic arrest-associated apoptosis induced by sodium arsenite in A375 melanoma cells is BUBR1-dependent. Toxicol Appl Pharmacol 2008, 231:61-67.
138. Mendez F., Sandigursky M., Franklin W.A., Kenny M.K., Kureekattil R., Bases R. Heat-shock proteins associated with base excision repair enzymes in HeLa cells. Radiat Res 2000, 153:186-195.
139. Méndez-Gómez J., García-Vargas G.G., López-Carrillo L., Calderón-Aranda E.S., Gómez A., Vera E., et al. Genotoxic effects of environmental exposure to arsenic and lead on children in region Lagunera, Mexico. Ann NY Acad Sci 2008, 40:358-367.
140. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
141. Moore L.E., Warner M.L., Smith A.H., Kalman D., Smith M.T. Use of the fluorescent micronucleus assay to detect the genotoxic effects of radiation and arsenic exposure in exfoliated human epithelial cells. Environ Mol Mutagen 1996, 27:176-184.
142. Moore L.E., Smith A.H., Hopenhayn-Rich C., Biggs M.L., Kalman D.A., Smith M.T. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol Biomarkers Prev 1997, 6:31-36.
143. Moore L.E., Smith A.H., Eng C., Kalman D., DeVries S., Bhargava V., et al. Arsenic-related chromosomal alterations in bladder cancer. J Natl Cancer Inst 2002, 94:1688-1696.
144. Moore L.E., Smith A.H., Eng C., Kalman D., DeVries S., Bhargava V., et al. Arsenic-related chromosomal alterations in bladder cancer. J Natl Cancer Inst 2002, 22:1688-1696.
145. Morales K.H., Ryan L., Kuo T.L., Wu M.M., Chen C.J. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect 2000, 108:655-661.
146. Mourón S.A., Golijow C.D., Dulout F.N. DNA damage by cadmium and arsenic salts assessed by the single cell gel electrophoresis assay. Mutat Res 2001, 498:47-55.
147. Mourón S.A., Grillo C.A., Dulout F.N., Golijow C.D. Induction of DNA strand breaks, DNA-protein crosslinks and sister chromatid exchanges by arsenite in a human lung cell line. Toxicol In Vitro 2006, 20:279-285.
148. Negrini S., Gorgoulis V.G., Halazonetis T.D. Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010, 11:220-228.
149. Oulton R., Harrington L. Telomeres, telomerase, and cancer: life on the edge of genomic stability. Curr Opin Oncol 2000, 12:74-81.
150. Paiva L., Martínez V., Creus A., Quinteros D., Marcos R. Evaluation of micronucleus frequencies in blood lymphocytes from smelting plant workers exposed to arsenic. Environ Mol Mutagen 2008, 49:200-205.
151. Paldy A., Farkas I., Markus V., Gundy S. Chromosomal aberrations in children exposed to high concentration of arsenic in drinking water. 21st Annual Meeting of the European Mutagen Society (EEMS) on Environmental Mutagens-Carcinogens 1991.
152. Pi J., He Y., Bortner C., Huang J., Liu J., Zhou T., et al. Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: potential role in skin co-carcinogenesis. Int J Cancer 2005, 116:20-26.
153. Pi J., Diwan B.A., Sun Y., Liu J., Qu W., He Y., et al. Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2. Free Radic Biol Med 2008, 45:651-658.
154. Poonepalli A., Balakrishnan L., Khaw A.K., Low G.K., Jayapal M., Bhattacharjee R.N., et al. Lack of poly(ADP-ribose) polymerase-1 gene product enhances cellular sensitivity to arsenite. Cancer Res 2005, 65:10977-10983.
155. Pu Y.S., Yang S.M., Huang Y.K., Chung C.J., Huang S.K., Chiu A.W., et al. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol Appl Pharmacol 2007, 218:99-106.
156. Qin X.J., Hudson L.G., Liu W., Timmins G.S., Liu K.J. Low concentration of arsenite exacerbates UVR-induced DNA strand breaks by inhibiting PARP-1 activity. Toxicol Appl Pharmacol 2008, 232:41-50.
157. Qin X.J., Liu W., Li Y.N., Sun X., Hai C.X., Hudson L.G., et al. Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicol Sci 2012, 127:120-129.
158. Rabinowits G., Gerçel-Taylor C., Day J.M., Taylor D.D., Kloecker G.H. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009, 10:42-46.
159. Rai R., Chang S. Probing the telomere damage response. Methods Mol Biol 2011, 735:145-150.
160. Ramírez P., Eastmond D.A., Laclette J.P., Ostrosky-Wegman P. Disruption of microtubule assembly and spindle formation as a mechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat Res 1997, 386:291-298.
161. Ramírez T., Stopper H., Fischer T., Hock R., Herrera L.A. S-adenosyl-L-methionine counteracts mitotic disturbances and cytostatic effects induced by sodium arsenite in HeLa cells. Mutat Res 2008, 637:152-160.
162. Rao C.V., Yamada H.Y., Yao Y., Dai W. Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice. Carcinogenesis 2009, 30:1469-1474.
163. Rehman K., Naranmandura H. Arsenic metabolism and thioarsenicals. Metallomics 2012, 4:881-892.
164. Roboz G.J., Dias S., Lam G., Lane W.J., Soignet S.L., Warrell R.P., et al. Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 2000, 96:1525-1530.
165. Rodier F., Coppé J.P., Patil C.K., Hoeijmakers W.A., Muñoz D.P., Raza S.R., et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009, 11:973-979.
166. Rossner P., Boffetta P., Ceppi M., Bonassi S., Smerhovsky Z., Landa K., et al. Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect 2005, 113:517-520.
167. Rousselot P., Labaume S., Marolleau J.P., Larghero J., Noguera M.H., Brouet J.C., et al. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res 1999, 59:1041-1048.
168. Ruiz-Ramos R., Lopez-Carrillo L., Rios-Perez A.D., De Vizcaya-Ruíz A., Cebrian M.E. Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-κB activation and cell proliferation in human breast cancer MCF-7 cells. Muta Res 2009, 674:109-115.
169. Salazar A.M., Miller H.L., McNeely S.C., Sordo M., Ostrosky-Wegman P., States J.C. Suppression of p53 and p21CIP1/WAF1 reduces arsenite-induced aneuploidy. Chem Res Toxicol 2010, 23:357-364.
170. Sallmyr A., Fan J., Rassool F.V. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. Cancer Lett 2008, 270:1-9.
171. Sampayo-Reyes A., Hernández A., El-Yamani N., López-Campos C., Mayet-Machado E., Rincón-Castañeda C.B., et al. Arsenic induces DNA damage in environmentally exposed Mexican children and adults. Influence of GSTO1 and AS3MT polymorphisms. Toxicol Sci 2010, 117:63-71.
172. Sauer H., Wartenberg M., Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001, 11:173-186.
173. Schreiber V., Dantzer F., Ame J.C., de Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 2006, 7:517-528.
174. Schwerdtle T., Walter I., Mackiw I., Hartwig A. Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 2003, 24:967-974.
175. Sciandrello G., Barbaro R., Caradonna F., Barbata G. Early induction of genetic instability and apoptosis by arsenic in cultured Chinese hamster cells. Mutagenesis 2002, 17:99-103.
176. Sciandrello G., Caradonna F., Mauro M., Barbata G. Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis 2004, 25:413-417.
177. Shahar O.D., Ram E.V., Shimshoni E., Hareli S., Meshorer E., Goldberg M. Live imaging of induced and controlled DNA double-strand break formation reveals extremely low repair by homologous recombination in human cells. Oncogene 2012, 31:3495-3504.
178. Shay J.W., Wright W.E. Role of telomeres and telomerase in cancer. Semin Cancer Biol 2011, 21:349-353.
179. Shen Z. Genomic instability and cancer: an introduction. J Mol Cell Biol 2011, 3:1-3.
180. Shen Z.Y., Tan L.J., Cai W.J., Shen J., Chen C., Tang X.M., et al. Arsenic trioxide induces apoptosis of oesophageal carcinoma in vitro. Int J Mol Med 1999, 4:33-37.
181. Shen Z.Y., Xu L.Y., Li E.M., Cai W.J., Chen M.H., Shen J., et al. Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell. World J Gastroenterol 2002, 8:357-362.
182. Shi H., Hudson L.G., Ding W., Wang S., Cooper K.L., Liu S., et al. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem Res Toxicol 2004, 17:871-878.
183. Snow E.T., Sykora P., Durham T.R., Klein C.B. Arsenic, mode of action at biologically plausible low doses: What are the implications for low dose cancer risk?. Toxicol Appl Pharmacol 2005, 207:557-564.
184. States J.C., Reiners J.J., Pounds J.G., Kaplan D.J., Beauerle B.D., McNeely S.C., et al. Arsenite disrupts mitosis and induces apoptosis in SV40-transformed human skin fibroblasts. Toxicol Appl Pharmacol 2002, 180:83-91.
185. Steinmaus C., Yuan Y., Bates M.N., Smith A.H. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 2003, 158:1193-1201.
186. Stoehr C., Burger M., Stoehr R., Bertz S., Ruemmele P., Hofstaedter F., et al. Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinoma. Pathobiology 2012, 79:162-168.
187. Sudo T., Nitta M., Saya H., Ueno N.T. Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res 2004, 64:2502-2508.
188. Suzuki T., Miyazaki K., Kita K., Ochi T. Trivalent dimethylarsenic compound induces histone H3 phosphorylation and abnormal localization of Aurora B kinase in HepG2 cells. Toxicol Appl Pharmacol 2009, 241:275-282.
189. Sykora P., Snow E.T. Modulation of DNA polymerase beta-dependent base excision repair in cultured human cells after low dose exposure to arsenite. Toxicol Appl Pharmacol 2008, 228:385-394.
190. Taylor B.F., McNeely S.C., Miller H.L., Lehmann G.M., McCabe M.J., States J.C. p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1. J Pharmacol Exp Ther 2006, 318:142-151.
191. Taylor B.F., McNeely S.C., Miller H.L., States J.C. Arsenite-induced mitotic death involves stress response and is independent of tubulin polymerization. Toxicol Appl Pharmacol 2008, 230:235-246.
192. Tennant A.H., Kligerman A.D. Superoxide dismutase protects cells from DNA damage induced by trivalent methylated arsenicals. Environ Mol Mutagen 2011, 52(3):238-243. (Apr).
193. Tezuka M., Hanioka K., Yamanaka K., Okada S. Gene damage induced in human alveolar type II (L-132) cells by exposure to dimethylarsinic acid. Biochem Biophys Res Commun 1993, 191:1178-1183.
194. Thirumaran R.K., Bermejo J.L., Rudnai P., Gurzau E., Koppova K., Goessler W., et al. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 2006, 27:1676-1681.
195. Thomas D.J., Waters S.B., Styblo M. Elucidating the pathway for arsenic methylation. Toxicol Appl Pharmacol 2004, 198:319-326.
196. Thomas D.J., Li J., Waters S.B., Xing W., Adair B.M., Drobna Z., et al. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp Biol Med (Maywood) 2007, 232:3-13.
197. Tian D., Ma H., Feng Z., Xia Y., Le X.C., Ni Z., et al. Analyses of micronuclei in exfoliated epithelial cells from individuals chronically exposed to arsenic via drinking water in inner Mongolia, China. J Toxicol Environ Health A 2001, 64:473-484.
198. Tokar E.J., Diwan B.A., Ward J.M., Delker D.A., Waalkes M.P. Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 mice. Toxicol Sci 2011, 119:73-83.
199. Tseng C.H., Huang Y.K., Huang Y.L., Chung C.J., Yang M.H., Chen C.J., et al. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 2005, 206:299-308.
200. Tsou T.C., Tsai F.Y., Yeh S.C., Chang L.W. ATM/ATR-related checkpoint signals mediate arsenite-induced G2/M arrest in primary aortic endothelial cells. Arch Toxicol 2006, 80:804-810.
201. Valenzuela O.L., Drobná Z., Hernández-Castellanos E., Sánchez-Peña L.C., García-Vargas G.G., Borja-Aburto V.H., et al. Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol Appl Pharmacol 2009, 239:200-207.
202. Vitale I., Galluzzi L., Castedo M., Kroemer G. Mitotic catastrophe a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 2011, 12:385-392.
203. Vogt B.L., Rossman T.G. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts - a possible mechanism for arsenite's comutagenicity. Mutat Res 2001, 478:159-168.
204. Vuyyuri S.B., Ishaq M., Kuppala D., Grover P., Ahuja Y.R. Evaluation of micronucleus frequencies and DNA damage in glass workers exposed to arsenic. Environ Mol Mutagen 2006, 47:562-570.
205. Waalkes M.P., Ward J.M., Liu J., Diwan B.A. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol 2003, 186:7-17.
206. Wang Z.G., Rivi R., Delva L., König A., Scheinberg D.A., Gambacorti-Passerini C., et al. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner. Blood 1998, 92:1497-1504.
207. Wang T.S., Hsu T.Y., Chung C.H., Wang A.S., Bau D.T., Jan K.Y. Arsenite induces oxidative DNA adducts and DNA-protein cross-links in mammalian Cells. Free Radic Biol Med 2001, 31:321-330.
208. Wang T.S., Chung C.H., Wang A.S., Bau D.T., Samikkannu T., Jan K.Y., et al. Endonuclease III, formamidopyrimidine-DNA glycosylase, and proteinase K additively enhance arsenic-induced DNA strand breaks in human cells. Chem Res Toxicol 2002, 15:1254-1258.
209. Warner M.L., Moore L.E., Smith M.T., Kalman D.A., Fanning E., Smith A.H. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev 1994, 3:583-590.
210. Wei W., Sedivy J.M. Differentiation between senescence (M1) and crisis (M2) in human fibroblast cultures. Exp Cell Res 1999, 253:519-522.
211. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair and susceptibility to basal cell carcinoma: a case-control study. Am J Epidemiol 1994, 140:598-607.
212. Wei M., Wanibuchi H., Morimura K., Iwai S., Yoshida K., Endo G., et al. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 2002, 23:1387-1397.
213. Wen J., Wen W., Li L., Liu H. Methylation capacity of arsenic and skin lesions in smelter plant workers. Environ Toxicol Pharmacol 2012, 34:624-630.
214. Wnek S.M., Jensen T.J., Severson P.L., Futscher B.W., Gandolfi A.J. Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol Sci 2010, 116:44-57.
215. Wnek S.M., Kuhlman C.L., Camarillo J.M., Medeiros M.K., Liu K.J., Lau S.S., et al. Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicol Appl Pharmacol 2011, 257:1-13.
216. Wu Y.C., Yen W.Y., Yih L.H. Requirement of a functional spindle checkpoint for arsenite-induced apoptosis. J Cell Biochem 2008, 105:678-687.
217. Wu Y.C., Yen W.Y., Lee T.C., Yih L.H. Heat shock protein inhibitors, 17-DMAG and KNK437, enhance arsenic trioxide-induced mitotic apoptosis. Toxicol Appl Pharmacol 2009, 236:231-238.
218. Wyllie A.H., Bellamy C.O., Bubb V.J., Clarke A.R., Corbet S., Curtis L., et al. Apoptosis and carcinogenesis. Br J Cancer 1999, 80:34-37.
219. Yamada N.A., Farber R.A. Induction of a low level of microsatellite instability by overexpression of DNA polymerase Beta. Cancer Res 2002, 62:6061-6064.
220. Yamanaka K., Mizoi M., Kato K., Hasegawa A., Nakano M., Okada S. Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Biol Pharm Bull 2001, 24(5):510-514.
221. Yamanaka K., Mizoi M., Tachikawa M., Hasegawa A., Hoshino M., Okada S. Oxidative DNA damage following exposure to dimethylarsinous iodide: the formation of cisthymine glycol. Toxicol Lett 2003, 143(2):145-153.
222. Yáñez L., García-Nieto E., Rojas E., Carrizales L., Mejía J., Calderón J., et al. DNA damage in blood cells from children exposed to arsenic and lead in a mining area. Environ Res 2003, 93:231-240.
223. Yang P., He X.Q., Peng L., Li A.P., Wang X.R., Zhou J.W., et al. The role of oxidative stress in hormesis induced by sodium arsenite in human embryo lung fibroblast (HELF) cellular proliferation model. J Toxicol Environ Health A 2007, 70:976-983.
224. Yen Y.P., Tsai K.S., Chen Y.W., Huang C.F., Yang R.S., Liu S.H. Arsenic induces apoptosis in myoblasts through a reactive oxygen species-induced endoplasmic reticulum stress and mitochondrial dysfunction pathway. Arch Toxicol 2012, 86:923-933.
225. Yih L.H., Lee T.C. Effects of exposure protocols on induction of kinetochore-plus and -minus micronuclei by arsenite in diploid human fibroblasts. Mutat Res 1999, 440:75-82.
226. Yih L.H., Hsueh S.W., Luu W.S., Chiu T.H., Lee T.C. Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells. Carcinogenesis 2005, 26:53-63.
227. Zhang W., Ohnishi K., Shigeno K., Fujisawa S., Naito K., Nakamura S., et al. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 1998, 12:1383-1391.
228. Zhang T.C., Schmitt M.T., Mumford J.L. Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro. Carcinogenesis 2003, 24:1811-1817.
229. Zhang Y., Cao E.H., Liang X.Q., Qin J.F. Increasing sensitivity to arsenic trioxide-induced apoptosis by altered telomere state. Eur J Pharmacol 2003, 474:141-147.
230. Zhao R., Hou Y., Xue P., Woods C.G., Fu J., Feng B., et al. Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes. Environ Health Perspect 2011, 119:56-62.
231. Zheng J., Deng Y.P., Lin C., Fu M., Xiao P.G., Wu M. Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression. Int J Cancer 1999, 82:286-292.
232. Zhou X., Sun X., Cooper K.L., Wang F., Liu K.J., Hudson L.G. Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. J Biol Chem 2011, 286:22855-22863.